Close

Johnson & Johnson (JNJ) COVID-19 Vaccine Roll-out to Resume in Europe Following EMA Review

Go back to Johnson & Johnson (JNJ) COVID-19 Vaccine Roll-out to Resume in Europe Following EMA Review
Johnson & Johnson (NYSE: JNJ) Delayed: 145.42 -0.32 (0.22%)
Previous Close $145.74    52 Week High $126.07 
Open $146.15    52 Week Low $94.28 
Day High $146.16    P/E 30.23 
Day Low $144.54    EPS $4.81 
Volume 854,380